Carlos Santonja

Carlos Santonja

Auto-generated profile, based on publicly available information

Carlos Santonja

Department of Pathology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in European Journal of Cancer
Verified
Journal Article
Open access
SHSarah Haggenmüller
Sarah Haggenmüller
RMRoman C. Maron
Roman C. Maron
AHAchim Hekler
Achim Hekler
JUJochen S. Utikal
Jochen S. Utikal
Catarina BarataCatarina Barata
Catarina Barata
TBTitus Josef Brinker
Titus Josef Brinker
Multiple studies have compared the performance of artificial intelligence (AI)-based models for automated skin cancer classification to human experts, thus setting the cornerstone for a successful translation of AI-based tools into clinicopathological practice. The objective of the study was to systematically analyse the current state of research on reader studies involving melanoma and to assess their potential clinical relevance by evaluating three main aspects: test set characteristics (holdout/out-of-distribution data set, composition), test setting (experimental/clinical, inclusion of metadata) and representativeness of participating clinicians. PubMed, Medline and ScienceDirect were screened for peer-reviewed studies published between 2017 and 2021 and dealing with AI-based skin cancer classification involving melanoma. The search terms skin cancer classification, deep learning, convolutional neural network (CNN), melanoma (detection), digital biomarkers, histopathology and whole slide imaging were combined. Based on the search results, only studies that considered direct comparison of AI results with clinicians and had a diagnostic classification as their main objective were included. A total of 19 reader studies fulfilled the inclusion criteria. Of these, 11 CNN-based approaches addressed the classification of dermoscopic images; 6 concentrated on the classification of clinical images, whereas 2 dermatopathological studies utilised digitised histopathological whole slide images. All 19 included studies demonstrated superior or at least equivalent performance of CNN-based classifiers compared with clinicians. However, almost all studies were conducted in highly artificial settings based exclusively on single images of the suspicious lesions. Moreover, test sets mainly consisted of holdout images and did not represent the full range of patient populations and melanoma subtypes encountered in clinical practice.


7 September 2017 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
CSC. Santonja
C. Santonja
ASA. Santos-Briz
A. Santos-Briz
GPG. Palmedo
G. Palmedo
HKH. Kutzner
H. Kutzner
LRL. Requena
L. Requena

12 June 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRebeca Manso
Rebeca Manso
NMNerea Martínez-Magunacelaya
Nerea Martínez-Magunacelaya
IEItziar Eraña-Tomás
Itziar Eraña-Tomás
VMVerónica Monsalvez
Verónica Monsalvez
JRJose Luis Rodriguez-Peralto
Jose Luis Rodriguez-Peralto
Socorro María Rodríguez-PinillaSocorro María Rodríguez-Pinilla
Socorro María Rodríguez-Pinilla
Differentiating early mycosis fungoides (MF) from inflammatory dermatitis is a challenge. We compare the differential expression profile of early-stage MF samples and benign inflammatory dermatoses using microRNA (miRNA) arrays. 114 miRNAs were found to be dysregulated between these entities. The seven most differentially expressed miRNAs between these two conditions were further analyzed using RT-PCR in two series comprising 38 samples of early MFs and 18 samples of inflammatory dermatitis. A series of 51 paraffin-embedded samples belonging to paired stages of 16 MF patients was also analyzed. MiRNAs 26a, 222, 181a and 146a were differentially expressed between tumoral and inflammatory conditions. Two of these miRNAs (miRNA-181a and miRNA-146a) were significantly deregulated between early and advanced MF stages. Bioinformatic analysis showed FOXP3 expression to be regulated by these miRNAs. Immunohistochemistry revealed the level of FOXP3 expression to be lower in tumoral MFs than in plaque lesions in paraffin-embedded tissue. A functional study confirmed that both miRNAs diminished FOXP3 expression when overexpressed in CTCL cells. The data presented here suggest that the analysis of a restricted number of miRNAs (26a, 222, 181a and 146a) could be sufficient to differentiate tumoral from reactive conditions. Moreover, these miRNAs seem to be involved in MF progression.

1 May 2012 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
CSCarlos Santonja
Carlos Santonja
IGInés Gonzalo
Inés Gonzalo
MFMarta Feito
Marta Feito
MBMaríajosé Beato-Merino
Maríajosé Beato-Merino
LRLuis Requena
Luis Requena
We describe the clinical, histopathologic, immunohistochemical, and molecular findings in an additional case of lipoatrophic panniculitis selectively involving the ankles in a 12-year-old boy. This idiopathic, rarely reported entity is presumed to have an autoimmune pathogenesis. Histological findings are a lipophagic lobular panniculits, that in our case featured focally increased numbers of lymphocytes rimming the adipocytes, and infiltration of vascular walls by mildly atypical lymphoid cells, raising the differential diagnosis of subcutaneous panniculitis-like T-cell lymphoma.

20 July 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMaría-Dolores Mendoza
María-Dolores Mendoza
CSCarlos Santonja
Carlos Santonja
CGCarmen Gonzalez-Vela
Carmen Gonzalez-Vela
ACAngel Concha
Angel Concha
NINicolás Iglesias-Pena
Nicolás Iglesias-Pena
Miguel PirisMiguel Piris
Miguel Piris
Merkel cell carcinoma (MCC) is an aggressive primary neuroendocrine tumor of the skin, associated with Merkel cell polyomavirus (MCPyV) in 49–89% of cases, depending on the country of origin and the techniques of detection. The presence of MCPyV defines heterogeneity in MCC; MCPyV-negative cases bear a much higher mutational load, with a distinct ultraviolet signature pattern featuring C > T transitions, as a consequence of exposure to ultraviolet light radiation. MCC stroma has not been thoroughly studied, although MCC patients benefit from therapy targeting PD1/PDL1. In this study, using Tissue Microarrays and immunohistochemistry, we have analyzed a series of 219 MCC cases in relation to the presence of MCPyV, and confirmed that the presence of MCPyV is associated with changes not only in the neoplastic cells, but also in the composition of the tumor stroma. Thus, MCPyV, found in 101/176 (57,4%) analyzable cases, exhibits changes in its tumor morphology, the density of the inflammatory infiltrate, the phenotype of the neoplastic cells, and the cell composition of the tumor stroma. MCPyV presence is negatively correlated with a higher level of p53 expression, and associated with a very high frequency (86%) of HLA-I expression loss, a higher apoptotic index, and a stroma richer in T-cells, cytotoxic T-cells, macrophages, PDL1-positive macrophages, and B-cells. Our findings provide evidence of the basic heterogeneity of MCC, supporting the hypothesis that the presence of MCPyV may induce a rich inflammatory response, which is at least partially avoided through loss of HLA-I antigen expression. On the other hand, MCPyV-negative cases show a much higher frequency of stronger p53 expression and, probably, p53 alterations.